These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28273146)

  • 1. Evaluation of an automated connective tissue disease screening assay in Korean patients with systemic rheumatic diseases.
    Jeong S; Yang H; Hwang H
    PLoS One; 2017; 12(3):e0173597. PubMed ID: 28273146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an Automated Screening Assay, Compared to Indirect Immunofluorescence, an Extractable Nuclear Antigen Assay, and a Line Immunoassay in a Large Cohort of Asian Patients with Antinuclear Antibody-Associated Rheumatoid Diseases: A Multicenter Retrospective Study.
    Jeong S; Hwang H; Roh J; Shim JE; Kim J; Kim GT; Tag HS; Kim HS
    J Immunol Res; 2018; 2018():9094217. PubMed ID: 29854849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of anti-nuclear antibodies from filter paper blood clots using indirect immunoenzyme technique: preliminary experience and results.
    Chopra A; Anuradha V; Edmonds J
    J Assoc Physicians India; 2000 May; 48(5):493-6. PubMed ID: 11273141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of antinuclear antibody connective tissue disease screen.
    López-Hoyos M; Rodríguez-Valverde V; Martinez-Taboada V
    Ann N Y Acad Sci; 2007 Aug; 1109():322-9. PubMed ID: 17785321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.
    Op De Beeck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
    Autoimmun Rev; 2011 Oct; 10(12):801-8. PubMed ID: 21741497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of the Connective Tissue Screening Questionnaire in northeast Pennsylvania to identify comorbidities of connective tissue diseases in subjects with systemic lupus erythematosus.
    Farrell MS; Wallace SJ; Clarke SM; Tarafder MR; McLaughlin WA
    J Prim Care Community Health; 2014 Apr; 5(2):134-8. PubMed ID: 24327597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for connective tissue disease-associated antibodies by automated immunoassay.
    Willems P; De Langhe E; Claessens J; Westhovens R; Van Hoeyveld E; Poesen K; Vanderschueren S; Blockmans D; Bossuyt X
    Clin Chem Lab Med; 2018 May; 56(6):909-918. PubMed ID: 29306915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies.
    Claessens J; Belmondo T; De Langhe E; Westhovens R; Poesen K; Hüe S; Blockmans D; Mahler M; Fritzler MJ; Bossuyt X
    Autoimmun Rev; 2018 Jun; 17(6):533-540. PubMed ID: 29526634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
    González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
    Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early undifferentiated connective tissue disease. IV.Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with well-established connective tissue diseases: followup analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baseline.
    Alarcón GS; Willkens RF; Ward JR; Clegg DO; Morgan JG; Ma KN; Singer JZ; Steen VD; Paulus HE; Luggen ME; Polisson RP; Ziminski CM; Yarboro C; Williams HJ
    Arthritis Rheum; 1996 Mar; 39(3):403-14. PubMed ID: 8607889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease.
    Alarcón GS; Williams GV; Singer JZ; Steen VD; Clegg DO; Paulus HE; Billingsley LM; Luggen ME; Polisson RP; Willkens RF
    J Rheumatol; 1991 Sep; 18(9):1332-9. PubMed ID: 1757934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and prognostic factors in patients with connective tissue disease-associated pulmonary hypertension diagnosed by echocardiography: results from a Korean nationwide registry.
    Kang KY; Jeon CH; Choi SJ; Yoon BY; Choi CB; Lee CH; Suh CH; Lee CW; Cho CS; Nam EJ; Koh EM; Kim HY; Choi HJ; Kim HA; Jun JB; Lee J; Kim J; Ji JD; Min JK; Kim KJ; Shin K; So MW; Kwon SR; Kim SK; Nah SS; Kwok SK; Lee SK; Lee SW; Park SH; Park W; Park YB; Lee YH; Lee SS; Yoo DH
    Int J Rheum Dis; 2017 Sep; 20(9):1227-1236. PubMed ID: 26214170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A connective tissue disease screening questionnaire for population studies.
    Karlson EW; Sanchez-Guerrero J; Wright EA; Lew RA; Daltroy LH; Katz JN; Liang MH
    Ann Epidemiol; 1995 Jul; 5(4):297-302. PubMed ID: 8520712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of borderline results of the Elia CTD Screen assay.
    Robier C; Amouzadeh-Ghadikolai O
    Clin Chem Lab Med; 2018 Nov; 56(12):2088-2092. PubMed ID: 30032128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum autoantibodies profile and increased levels of circulating intercellular adhesion molecule-1: a reflection of the immunologically mediated systemic vasculopathy in rheumatic diseases?
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):423-30. PubMed ID: 11814236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Screening Dilution and Automated Reading for Antinuclear Antibody Detection on HEP2 Cells in the Monitoring of Connective Tissue Diseases.
    Depincé-Berger AE; Moreau A; Bossy V; Genin C; Rinaudo M; Paul S
    J Clin Lab Anal; 2016 Sep; 30(5):471-8. PubMed ID: 27225012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated with Erosive Arthritis in Rheumatoid Arthritis and Other Connective Tissue Diseases: A Retrospective Study From a Southern Chinese Population.
    Yuan S; Chen D; Xiao Y; Lao M; Qiu Q; Liang L; Yang X
    J Clin Rheumatol; 2016 Jan; 22(1):22-9. PubMed ID: 26693623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis.
    Jeong S; Yang D; Lee W; Kim GT; Kim HS; Ahn HS; Kim HJ
    Semin Arthritis Rheum; 2018 Oct; 48(2):334-342. PubMed ID: 29609799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low positive rate of serum autoantibodies in colorectal cancer patients without systemic rheumatic diseases.
    Fernández-Suárez A; Muñoz-Colmenero A; Ocaña-Pérez E; Fatela-Cantillo D; Domínguez-Jiménez JL; Díaz-Iglesias JM
    Autoimmunity; 2016 Sep; 49(6):383-387. PubMed ID: 27424781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence and specificity of antineutrophil cytoplasmic antibodies (ANCA) in connective tissue diseases].
    Puszczewicz M; Zimmermann-Górska I; Białkowska-Puszczewicz G; Tuchocka A
    Pol Arch Med Wewn; 2003 Jan; 109(1):35-41. PubMed ID: 12879764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.